Analysis of HLA-A, HLA-B and HLA-DRB1 alleles in Chinese patients with lung cancer

Genetics and Molecular Research

Volumn 9, Issue 2, 2010, Pages 750-755

  Yang, L ^a   Wang, L J ^b   Shi, G L ^a   Ni, L ^b   Song, C X ^a   Zhang, Z X ^b   Xu, S F ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b Beijing Red Cross Blood Center   (China)

Author keywords

Gene frequency; Human leukocyte antigen; Lung carcinoma

Indexed keywords

HLA A ANTIGEN; HLA B ANTIGEN; HLA DR ANTIGEN;

ADULT; AGED; ALLELE; ARTICLE; CANCER RESISTANCE; CANCER SUSCEPTIBILITY; CHINA; CHINESE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC ANALYSIS; GENETIC POLYMORPHISM; HUMAN; HUMAN CELL; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS;

ADULT; AGED; ALLELES; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; CHINA; FEMALE; GENE FREQUENCY; HLA-A ANTIGENS; HLA-B ANTIGENS; HLA-DR ANTIGENS; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED;

EID: 77954448484     PISSN: None     EISSN: 16765680     Source Type: Journal    
DOI: 10.4238/vol9-2gmr735     Document Type: Article

References (31)

1. Ainsworth PJ, Surh LC and Coulter-Mackie MB (1991). Diagnostic single strand conformational polymorphism (SSCP): a simplified non-radioisotopic method as applied to a Tay-Sachs B1 variant. Nucleic Acids Res. 19: 405-406.
2. Bidwell JL, Bidwell EA, Savage DA, Middleton D, et al. (1988). A DNA-RFLP typing system that positively identifies serologically well-defined and ill-defined HLA-DR and DQ alleles, including DRw10. Transplantation 45: 640-646.
3. Bjorkman PJ, Saper MA, Samraoui B, Bennett WS, et al. (1987). The foreign antigen binding site and T cell recognition regions of class I histocompatibility antigens. Nature 329: 512-518.
4. Cantú de León D, Perez-Montiel D, Villavicencio V, Garcia CA, et al. (2009). High resolution human leukocyte antigen (HLA) class I and class II allele typing in Mexican mestizo women with sporadic breast cancer: case-control study. BMC Cancer 9: 48.
5. Chen WQ, Zhang SW and Kong LS (2008). Cancer mortality report of 34 registries in China, 2004. Bull. Chin. Cancer 17: 913-916.
6. Dalva K and Beksac M (2007). HLA typing with sequence-specific oligonucleotide primed PCR (PCR-SSO) and use of the Luminex technology. Methods Mol. Med. 134: 61-69.
7. Davis RW, Thomas M, Cameron J, St John TP, et al. (1980). Rapid DNA isolations for enzymatic and hybridization analysis. Methods Enzymol. 65: 404-411.
8. Dorak MT, Oguz FS, Yalman N, Diler AS, et al. (2002). A male-specific increase in the HLA-DRB4 (DR53) frequency in high-risk and relapsed childhood ALL. Leuk. Res. 26: 651-656.
9. Ferlay J, Autier P, Boniol M, Heanue M, et al. (2007). Estimates of the cancer incidence and mortality in Europe in 2006. Ann. Oncol. 18: 581-592.
10. Gresner P, Gromadzinska J and Wasowicz W (2007). Polymorphism of selected enzymes involved in detoxification and biotransformation in relation to lung cancer. Lung Cancer 57: 1-25.
11. Haghpanah V, Khalooghi K, Adabi K, Amiri P, et al. (2009). Associations between HLA-C alleles and papillary thyroid carcinoma. Cancer Biomark. 5: 19-22.
12. Hoppe B and Salama A (2007). Sequencing-based typing of HLA. Methods Mol. Med. 134: 71-80.
13. Jemal A, Siegel R, Ward E, Hao Y, et al. (2009). Cancer statistics, 2009. CA Cancer J. Clin. 59: 225-249.
14. Kiyohara C, Takayama K and Nakanishi Y (2006). Association of genetic polymorphisms in the base excision repair pathway with lung cancer risk: a meta-analysis. Lung Cancer 54: 267-283.
15. Kübler K, Arndt PF, Wardelmann E, Krebs D, et al. (2006). HLA-class II haplotype associations with ovarian cancer. Int. J. Cancer 119: 2980-2985.
16. Madeleine MM, Johnson LG, Smith AG, Hansen JA, et al. (2008). Comprehensive analysis of HLA-A, HLA-B, HLA-C, HLA-DRB1, and HLA-DQB1 loci and squamous cell cervical cancer risk. Cancer Res. 68: 3532-3539.
17. Marsh SG (2003). HLA nomenclature and the IMGT/HLA sequence database. Novartis Found. Symp. 254: 165-173.
18. Miller SA, Dykes DD and Polesky HF (1988). A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 16: 1215.
19. Mundhada S, Luthra R and Cano P (2004). Association of HLA Class I and Class II genes with bcr-abl transcripts in leukemia patients with t(9;22) (q34;q11). BMC Cancer 4: 25.
20. Olerup O and Zetterquist H (1992). HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours: an alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation. Tissue Antigens 39: 225-235.
21. Parkin DM, Bray F, Ferlay J and Pisani P (2005). Global cancer statistics, 2002. CA Cancer J. Clin. 55: 74-108.
22. Quintero E, Pizarro MA, Rodrigo L, Pique JM, et al. (2005). Association of Helicobacter pylori-related distal gastric cancer with the HLA class II gene DQB10602 and cagA strains in a southern European population. Helicobacter 10: 12-21.
23. Schiff MA, Apple RJ, Lin P, Nelson JL, et al. (2005). HLA alleles and risk of cervical intraepithelial neoplasia among southwestern American Indian women. Hum. Immunol. 66: 1050-1056.
24. Terasaki PI and McClelland JD (1964). Microdroplet assay of human serum cytotoxins. Nature 204: 998-1000.
25. Tokumoto H (1998). Analysis of HLA-DRB1-related alleles in Japanese patients with lung cancer - relationship to genetic susceptibility and resistance to lung cancer. J. Cancer Res. Clin. Oncol. 124: 511-516.
26. Wu MS, Hsieh RP, Huang SP, Chang YT, et al. (2002). Association of HLA-DQB1*0301 and HLA-DQB1*0602 with different subtypes of gastric cancer in Taiwan. Jpn. J. Cancer Res. 93: 404-410.
27. Wu Y, Liu B, Lin W, Xu Y, et al. (2007). Human leukocyte antigen class II alleles and risk of cervical cancer in China. Hum. Immunol. 68: 192-200.
28. Yari F, Sobhani M, Sabaghi F, Zaman-Vaziri M, et al. (2008). Frequencies of HLA-DRB1 in Iranian normal population and in patients with acute lymphoblastic leukemia. Arch. Med. Res. 39: 205-208.
29. Yoshimura C, Nomura S, Yamaoka M, Ohtani T, et al. (2000). Analysis of serum ErbB-2 protein and HLA-DRB1 in Japanese patients with lung cancer. Cancer Lett. 152: 87-95.
30. Young NT and Darke C (1993). Allelic typing of the HLA-DR4 group by polymerase chain reaction-single-strand conformation polymorphism analysis. Hum. Immunol. 37: 69-74.
31. Zhang SW, Chen WQ and Lei ZI (2008). A report of cancer incidence from 37 cancer registries in China, 2004. Bull. Chin. Cancer 17: 909-912